| 1 |
32049016 | Discovery of O-Linked Carbohydrate on HIV-1 Envelope and Its Role in Shielding against One Category of Broadly Neutralizing Antibodies. | 2020 Feb 11 |
1 |
| 2 |
30814513 | Rationally designed carbohydrate-occluded epitopes elicit HIV-1 Env-specific antibodies. | 2019 Feb 27 |
2 |
| 3 |
31704652 | HIV-1 Envelope Glycan Composition as a Key Determinant of Efficient Virus Transmission via DC-SIGN and Resistance to Inhibitory Lectins. | 2019 Nov 22 |
2 |
| 4 |
28386256 | Host Immune Responses in HIV-1 Infection: The Emerging Pathogenic Role of Siglecs and Their Clinical Correlates. | 2017 |
2 |
| 5 |
28824609 | Protein-Protein Interaction between Surfactant Protein D and DC-SIGN via C-Type Lectin Domain Can Suppress HIV-1 Transfer. | 2017 |
1 |
| 6 |
25380763 | Crystal structure of the HIV neutralizing antibody 2G12 in complex with a bacterial oligosaccharide analog of mammalian oligomannose. | 2015 Apr |
2 |
| 7 |
24556146 | Monovalent mannose-based DC-SIGN antagonists: targeting the hydrophobic groove of the receptor. | 2014 Mar 21 |
1 |
| 8 |
25018023 | Human herpesvirus 8 glycoprotein B binds the entry receptor DC-SIGN. | 2014 Sep 22 |
1 |
| 9 |
25275130 | HIV-1 envelope glycan moieties modulate HIV-1 transmission. | 2014 Dec |
2 |
| 10 |
23767872 | Conference report: "Functional Glycomics in HIV Type 1 Vaccine Design" workshop report, Bethesda, Maryland, April 30-May 1, 2012. | 2013 Nov |
1 |
| 11 |
23895096 | Role of cations in the interaction of pradimicins with HIV-1 envelope gp120. | 2013 Aug |
1 |
| 12 |
23152926 | Evolution of cross-neutralizing antibody specificities to the CD4-BS and the carbohydrate cloak of the HIV Env in an HIV-1-infected subject. | 2012 |
1 |
| 13 |
23198686 | Dissecting the carbohydrate specificity of the anti-HIV-1 2G12 antibody by single-molecule force spectroscopy. | 2012 Dec 21 |
1 |
| 14 |
21440555 | Gold nanoparticles coated with oligomannosides of HIV-1 glycoprotein gp120 mimic the carbohydrate epitope of antibody 2G12. | 2011 Jul 29 |
1 |
| 15 |
21471192 | Solution structure of the monovalent lectin microvirin in complex with Man(alpha)(1-2)Man provides a basis for anti-HIV activity with low toxicity. | 2011 Jun 10 |
1 |
| 16 |
21543485 | An HIV-1 gp120 envelope human monoclonal antibody that recognizes a C1 conformational epitope mediates potent antibody-dependent cellular cytotoxicity (ADCC) activity and defines a common ADCC epitope in human HIV-1 serum. | 2011 Jul |
1 |
| 17 |
21715597 | Removal of two high-mannose N-linked glycans on gp120 renders human immunodeficiency virus 1 largely resistant to the carbohydrate-binding agent griffithsin. | 2011 Oct |
1 |
| 18 |
21799112 | Designed oligomers of cyanovirin-N show enhanced HIV neutralization. | 2011 Aug 23 |
1 |
| 19 |
22006924 | The highly conserved glycan at asparagine 260 of HIV-1 gp120 is indispensable for viral entry. | 2011 Dec 16 |
1 |
| 20 |
20034607 | Increased immunogenicity of HIV-1 p24 and gp120 following immunization with gp120/p24 fusion protein vaccine expressing alpha-gal epitopes. | 2010 Feb 17 |
1 |
| 21 |
20181792 | Polysaccharide mimicry of the epitope of the broadly neutralizing anti-HIV antibody, 2G12, induces enhanced antibody responses to self oligomannose glycans. | 2010 Jul |
1 |
| 22 |
18945777 | Design and expression of a dimeric form of human immunodeficiency virus type 1 antibody 2G12 with increased neutralization potency. | 2009 Jan |
1 |
| 23 |
19224860 | Oligomerization of the macrophage mannose receptor enhances gp120-mediated binding of HIV-1. | 2009 Apr 24 |
1 |
| 24 |
19856962 | Unprecedented glycosidase activity at a lectin carbohydrate-binding site exemplified by the cyanobacterial lectin MVL. | 2009 Nov 18 |
1 |
| 25 |
17928023 | Carbohydrate-binding agents (CBAs) inhibit HIV-1 infection in human primary monocyte-derived macrophages (MDMs) and efficiently prevent MDM-directed viral capture and subsequent transmission to CD4+ T lymphocytes. | 2008 Jan 20 |
1 |
| 26 |
18237398 | The carbohydrate at asparagine 386 on HIV-1 gp120 is not essential for protein folding and function but is involved in immune evasion. | 2008 Jan 31 |
1 |
| 27 |
18930512 | Glycan deletions in the HIV-1 gp120 V1/V2 domain compromise viral infectivity, sensitize the mutant virus strains to carbohydrate-binding agents and represent a specific target for therapeutic intervention. | 2008 Dec 5 |
2 |
| 28 |
17475258 | The alpha(1,2)-mannosidase I inhibitor 1-deoxymannojirimycin potentiates the antiviral activity of carbohydrate-binding agents against wild-type and mutant HIV-1 strains containing glycan deletions in gp120. | 2007 May 15 |
2 |
| 29 |
15003531 | Actinohivin, a novel anti-human immunodeficiency virus protein from an actinomycete, inhibits viral entry to cells by binding high-mannose type sugar chains of gp120. | 2004 Mar 26 |
1 |
| 30 |
12954207 | Structure-based, targeted deglycosylation of HIV-1 gp120 and effects on neutralization sensitivity and antibody recognition. | 2003 Sep 1 |
1 |
| 31 |
12064867 | Detection of orientation-specific anti-gp120 antibodies by a new N-glycanase protection assay. | 2002 Feb |
1 |
| 32 |
12072529 | The broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2G12 recognizes a cluster of alpha1-->2 mannose residues on the outer face of gp120. | 2002 Jul |
1 |
| 33 |
11457139 | The potent anti-HIV protein cyanovirin-N contains two novel carbohydrate binding sites that selectively bind to Man(8) D1D3 and Man(9) with nanomolar affinity: implications for binding to the HIV envelope protein gp120. | 2001 May 2 |
1 |
| 34 |
10570220 | Glycan and glycosaminoglycan binding properties of stromal cell-derived factor (SDF)-1alpha. | 2000 Jan |
1 |
| 35 |
11027165 | Production of HIV-1 gp120 in packed-bed bioreactor using the vaccinia virus/T7 expression system. | 2000 Sep-Oct |
1 |
| 36 |
10563771 | Synthesis of biotinylated glycoconjugates and their use in a novel ELISA for direct comparison of HIV-1 Gp120 recognition of GalCer and related carbohydrate analogues. | 1999 Nov-Dec |
1 |
| 37 |
9491908 | Analysis of the interaction of antibodies with a conserved enzymatically deglycosylated core of the HIV type 1 envelope glycoprotein 120. | 1998 Feb 10 |
2 |
| 38 |
9499113 | Human immunodeficiency virus (HIV) envelope binds to CXCR4 independently of CD4, and binding can be enhanced by interaction with soluble CD4 or by HIV envelope deglycosylation. | 1998 Mar |
1 |
| 39 |
21374492 | Inhibition of HIV Infection by Lectin Binding to gp120. | 1998 |
1 |
| 40 |
9455924 | Effect of mannosylated derivatives on HIV-1 infection of macrophages and lymphocytes. | 1997 Dec |
2 |
| 41 |
8634021 | Sensitivity of HIV-1 to neutralization by antibodies against O-linked carbohydrate epitopes despite deletion of O-glycosylation signals in the V3 loop. | 1996 |
1 |
| 42 |
7795416 | alpha 1-Acid glycoprotein binds human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein via N-linked glycans. | 1995 Feb |
1 |
| 43 |
8416385 | Glycosylation is necessary for the correct folding of human immunodeficiency virus gp120 in CD4 binding. | 1993 Jan |
7 |
| 44 |
1281869 | Carbohydrate determinant NeuAc-Gal beta (1-4) of N-linked glycans modulates the antigenic activity of human immunodeficiency virus type 1 glycoprotein gp120. | 1992 Dec |
1 |
| 45 |
1347797 | Influence of carbohydrate moieties on the immunogenicity of human immunodeficiency virus type 1 recombinant gp160. | 1992 Apr |
1 |
| 46 |
1518160 | [Structure and function of oligosaccharide chains of the envelope glycoprotein gp120 of human immunodeficiency virus type 1]. | 1992 Jun |
1 |
| 47 |
1618696 | Inhibition of human immunodeficiency virus-1 infection by human conglutinin-like protein: in vitro studies. | 1992 May |
2 |
| 48 |
1642554 | Structural variability of env and gag gene products from a highly cytopathic strain of HIV-1. | 1992 |
1 |
| 49 |
1682045 | N-Acetyl-beta-D-glucosaminyl-binding properties of the envelope glycoprotein of human immunodeficiency virus type 1. | 1991 Jun 25 |
1 |
| 50 |
2561054 | Oligosaccharide-mediated interactions of the envelope glycoprotein gp120 of HIV-1 that are independent of CD4 recognition. | 1989 Dec |
1 |